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Background: Nova-1 and Nova-2 are related neuronal proteins that were
initially cloned using antisera obtained from patients with the autoimmune
neurological disease paraneoplastic opsoclonus-myoclonus ataxia (POMA).
Both of these disease gene products contain three RNA-binding motifs known
as K-homology or KH domains, and their RNA ligands have been identified via
binding-site selection experiments. The KH motif structure has been determined
previously using NMR spectroscopy, but not using X-ray crystallography. Many
proteins contain more than one KH domain, yet there is no published structural
information regarding the behavior of such multimers.
Results: We have obtained the first X-ray crystallographic structures of
KH-domain-containing proteins. Structures of the third KH domains (KH3) of
Nova-1 and Nova-2 were determined by multiple isomorphous replacement and
molecular replacement at 2.6 Å and 2.0 Å, respectively. These highly similar
RNA-binding motifs form a compact protease-resistant domain resembling an
open-faced sandwich, consisting of a three-stranded antiparallel β sheet topped
by three α helices. In both Nova crystals, the lattice is composed of symmetric
tetramers of KH3 domains that are created by two dimer interfaces.
Conclusions: The crystal structures of both Nova KH3 domains are similar to
the previously determined NMR structures. The most significant differences
among the KH domains involve changes in the positioning of one or more of the
α helices with respect to the β sheet, particularly in the NMR structure of the
KH1 domain of the Fragile X disease protein FMR-1. Loop regions in the KH
domains are clearly visible in the crystal structure, unlike the NMR structures,
revealing the conformation of the invariant Gly–X–X–Gly segment that is
thought to participate in RNA-binding and of the variable region. The tetrameric
arrangements of the Nova KH3 domains provide insights into how KH domains
may interact with each other in proteins containing multiple KH motifs.
Introduction
RNA–protein interactions are central to a host of critical
cellular processes, including protein biosynthesis, pre-
mRNA processing, RNA localization and mRNA degrada-
tion [1]. Several conserved sequence motifs responsible
for RNA binding have been identified over the past
decade [2]; one of the most common of these is the
K-homology (KH) motif. Originally identified in the het-
erogeneous nuclear ribonucleoprotein (hnRNP) K protein
[3], KH motifs span about 70 residues with a characteris-
tic pattern of hydrophobic residues, an invariant
Gly–X–X–Gly segment, and a variable region. Since their
initial detection, a superfamily of approximately 50 KH-
containing proteins has been identified in eubacteria and
eukaryotes, with functions in processes as diverse as
translation, alternative splicing of mRNA, and mRNA
localization [3–19]. In many cases, multiple copies of the
KH motif are found in a given RNA-binding protein.
Determination of high-resolution structures of KH motifs
and elucidation of how multiple KH motifs interact with
each other will contribute to our understanding of a wide
range of biological systems.
The Nova-1 and Nova-2 proteins are autoantigens in the
human autoimmune neurological disease known as para-
neoplastic opsoclonus-myoclonus ataxia or POMA.
Patients with POMA experience loss of motor control in
their limbs and eyes, and have high titers of antibodies
directed against both Nova proteins, Nova-1 and Nova-2
[4,20–22]. Nova-1 and Nova-2 are expressed neuron-
specifically in the central nervous system (CNS). In
POMA patients, however, the Nova proteins are
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expressed in tumors (typically breast and fallopian
cancers) growing outside the CNS, thereby eliciting an
immune response to antigens that are normally consid-
ered to be non-self by virtue of their location only in the
protected environment of the CNS. The resulting
autoimmune attack on the CNS is believed to cause the
motor-control losses characteristic of POMA. Occasion-
ally, the malignancy underlying this paraneoplastic
syndrome is found to be in remission, and it may be that
Nova protein autoimmunity can contribute to tumor
immunity [22].
The two autoantigens are very similar in amino acid
sequence throughout their length (Nova-2 is 75% identi-
cal to Nova-1 over 492 residues), with very high
sequence conservation among their KH motifs (amino
acid identities range from 87–93%). Each Nova protein
has three KH motifs, with a relatively short connection
between the first and second (50 and 26 residues for
Nova-1 and Nova-2, respectively) and a much larger
spacing between the second and third (179 and 204 for
Nova-1 and Nova-2, respectively). This asymmetric
arrangement is also seen in other proteins containing
three KH motifs, including Ybr232c, and hnRNPs K, E1
and E2 (Figure 1). Both Nova proteins selectively bind
single-stranded RNA in a hairpin loop, with a preference
for sequences rich in UCAU tetrads [20,23]. Such
tandem tetrads have been found in the genes encoding
Nova-1 and in the inhibitory glycine receptor α2 subunit.
In both cases, the putative Nova-binding sites occur in
introns near alternatively spliced exons, suggesting that
Nova proteins regulate alternate splicing of the
inhibitory glycine receptor α2 and Nova-1 pre-mRNAs.
Efforts to define the RNA-interacting regions in Nova-1
have shown that the third KH motif is both necessary and
sufficient for sequence-specific RNA binding [21,23].
Solution nuclear magnetic resonance (NMR) spectroscopy
has already yielded two structures of individual KH
motifs. The sixth KH motif of vigilin (KH6) [24] consists
of a three-stranded, antiparallel β sheet backed by three
α helices. Two surface loops, one containing the invariant
Gly–X–X–Gly segment, are disordered. The structure of
the first KH motif of the Fragile X disease protein FMR-1
[25] is similar to the vigilin structure, except for the
absence of the shortest α helix and subtle differences in
the packing of the two remaining α helices.
In this paper, we present independently determined
X-ray crystal structures of individual Nova-1 and Nova-2
KH domains responsible for sequence-specific RNA
recognition. These two Nova KH3 structures are nearly
identical to one another, and are similar to the NMR
structures of vigilin KH6 and FMR-1 KH1. Our work on
the Nova KH domains provides the first high-resolution
X-ray structures of this motif, permitting visualization of
loop regions (including the invariant Gly–X–X–Gly
segment), which are not well defined by NMR spec-
troscopy. In addition, the crystal structures show that the
two KH domains adopt identical tetrameric lattice-
packing arrangements, providing insights into the behav-
ior of multi-KH-domain proteins.
Results and discussion
Proteolytic definition of the KH domain
Figure 1 illustrates alignments of all available sequences
of KH-containing proteins. Early attempts at sequence
alignments with fewer examples suggested that an inde-
pendently folding KH domain consists of about 45
residues [3]. As more KH-containing proteins were dis-
covered, however, sequence homologies suggested the
existence of a larger maxi-KH motif [24], and the original
consensus was renamed mini-KH motif. In an effort to
resolve this ambiguity, limited proteolysis combined
with high-resolution mass spectrometry was performed
on the full-length Nova-1 protein (see Materials and
methods section). This domain-mapping strategy
(reviewed in [26]) revealed that the protein consists 
of three proteolytically resistant globular domains
(Figure 2), corresponding to the three maxi-KH motifs
detected by sequence homology (Figure 1). The remain-
der of the molecule is highly susceptible to protease
degradation (Figure 2), consistent with those regions
being unstructured. Cleavage within the KH domains is
largely restricted to the variable regions, which were
shown by NMR spectroscopy to be solvent-exposed
[24,25]. Finally, incubation of full-length Nova-1 with a
short RNA containing three UCAU repeats yielded addi-
tional protease protection in the spacer region between
the second and third KH domains, suggesting that this
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Figure 1
Structure-based sequence alignment of KH domains.  See materials
and methods section for Genbank accession numbers. Residues
with strong (greater than 70%) and moderate (greater than 40%)
homology are highlighted in color. Purple and dark green signify
strong hydrophobic (Cys/Ala/Val/Leu/Iso/Phe/Tyr/Trp) and glycine
conservation respectively. The remaining color codes denote
moderate conservation: violet (hydrophobic), light green (Gly), dark
brown (Arg/Lys/Gly), dark blue (Arg/Lys), brown (Pro), yellow
(Asp/Glu), peach (Ser/Thr), and orange (hydrophilic:
Ser/Thr/Asn/Gln). Residues in large loops are abbreviated within the
sequence by the number of residues. Proteins with multiple KH
domains have the number of intervening residues between adjacent
KH domains listed in parentheses at the end of the sequence.
Threading Z scores for successful threading calculations (Z > 4.0)
are also tabulated at the end of each row along with the KH model
giving the best alignment (Nv1 = Nova-1 KH3, Nv2 = Nova-2 KH3,
Vig = vigilin KH6, FMR = FMR-1 KH1). Residue numbering for the
Nova KH3 constructs is presented alongside the Nova-1 and
Nova-2 KH3 sequences (# denotes residues in the hydrophobic
core and * indicates potential RNA-binding residues). Secondary
structural elements, strands (S) and helices (H), are indicated at the
bottom of the alignment.
region may play a supporting role in sequence-specific
RNA binding by Nova-1 KH3.
Crystallization and structure determination
With the insights gained from mass spectrometry and pro-
teolysis, Escherichia coli expression constructs were created
for the production of each individual KH domain in both
Nova-1 and Nova-2, as well as constructs encoding KH1
plus KH2, KH2 plus KH3, and trimmed KH1 plus KH2
plus KH3. In most cases, bacterial expression yielded
protein in inclusion bodies. Renaturation (see Materials
and methods section) was successful for the KH3 domains
of both Nova-1 and Nova-2. To determine the structure,
point mutations in both KH3 domains were prepared by
substituting either methionine or cysteine for conserved
aliphatic residues likely to be in the hydrophobic core. In
addition, a leucine→asparagine mutant for each KH3
domain was produced to mimic a clinically important
point mutant found in FMR-1 KH2 (see below) [27].
Dynamic light scattering (DLS) [28] and sedimentation
equilibrium analytical ultracentrifuge [29] measurements
provide information about the aggregation state of macro-
molecules in solution. DLS is particularly useful as a
screening step to gauge the likelihood of success in crys-
tallization trials [28]. The DLS data indicated that wild-
type Nova-1 and Nova-2 KH3 domains exist in aqueous
solution as homodimers at concentrations of about
3 mg/ml (data not shown). The DLS experiment also
indicated that both KH3 domain preparations were
monodisperse, suggesting that they had a high probabil-
ity of yielding crystals (see below). It must be stressed
that DLS results (positive or negative) should not be
regarded as an infallible predictor of crystallizability.
Monodispersity implies that the probability of obtaining
crystals is at least 0.75, whereas aggregated proteins yield
crystals with a probability of about 0.10 [30]. Sedimenta-
tion equilibrium data were acquired for the Nova-1 and
Nova-2 KH3 domains. Neither domain oligomerizes at
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Figure 2
Domain mapping of the Nova-1 protein.
Cleavage sites in full-length Nova-1 were
determined through proteolysis with mass
spectrometry measurements. The location of
the three maxi-KH motifs are illustrated as
boxes, with shading indicating the position of
each variable loop. Arrows indicate sites of
protease cleavage, with the large arrows
indicating rapid cleavage and the smaller
arrows slow cleavage; an asterisk indicates
reduced cleavage (> twofold difference) in the
presence of RNA.
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Table 1 
Nova-1 KH3 data collection statistics.
Derivative Resolution (Å) Reflections Completeness (%) Rsym* (%) Riso† Phasing
measured/unique overall/outer shell overall/outer shell power ‡
Native 15.0–2.7 17,697/2596 99.3/98.8 5.7/20.2 — —
Bakers 15.0–2.9 13,332/2067 97.4/99.5 7.5/24.9 0.50 3.25
DMA 15.0–3.0 7,405/1832 95.8/97.7 7.8/25.4 0.48 3.25
EMP 15.0–3.4 5,942/1294 96.3/99.2 7.9/21.0 0.31 2.28
Overall MIRAS figure of merit = 0.74. *Rsym = ∑|I–〈I〉|/∑I, where I is
the observed intensity and 〈I〉 is the average intensity obtained from
multiple observations of symmetry-related reflections. †Riso is the mean
fractional isomorphous difference: ∑(|Fph|–|Fp|)/∑|Fp|.
‡Phasing power = rms (|Fh|/E), where |Fh| is the heavy atom structure
factor amplitude and E is the residual lack of closure. Bakers, Bakers
dimercurial; DMA, dimercuric acetate; EMP, ethyl mercury phosphate.
concentrations below about 0.7 mg/ml in aqueous solu-
tion (data not shown).
As expected from the DLS results, crystals were obtained
with the wild-type KH3 domain of Nova-1 and its
Ala37→Cys mutant (see Figure 1 for the residue number-
ing scheme used throughout). Diffraction data were col-
lected from both crystals. Attempts to solve the phase
problem using molecular replacement with the NMR
structures of vigilin KH6 and FMR-1 KH1 failed, and the
structure of the Nova-1 KH3 domain was determined via
multiple isomorphous replacement using mercury-soaked
crystals of the Ala37→Cys mutant (Table 1). Diffraction
data were also obtained under cryogenic conditions for the
KH3 domain of Nova-2 (wild-type and an Ile10→Met
mutant) at 2.0 Å resolution. This structure was solved by
molecular replacement using the Nova-1 KH3 structure as
a search model (Table 2). The structure of the Nova-1
KH3 Ala37→Cys mutant was refined at 2.6 Å resolution
using the program CNS [31], giving an R factor of 0.245
and Rfree of 0.310 with good stereochemistry (Table 3).
The Nova-2 KH3 Ile10→Met structure was refined to
convergence, giving an R factor of 0.227 and Rfree of 0.285
with excellent stereochemistry (Table 3).
Structural overview of Nova-1 and Nova-2 KH3 domains
The three-dimensional structure of the Nova-2 KH3
domain is illustrated schematically in Figure 3. The single
domain α/β fold resembles an open-faced sandwich —
overall dimensions 15 Å (depth) × 25 Å (width) × 30 Å
(height). Secondary structural elements include one short
and two long α helices and a three-stranded, antiparallel
β sheet, arranged in the order S1–H1–H2–S2–S3–H3. The
three β strands are arranged in space in the order
S1–S3–S2, making a relatively flat β sheet (Figure 3). H1
and H3 cover one surface of the β sheet, and H2 forms an
edge of the quasi-planar structure (Figure 3). The most
conserved feature of the maxi-KH motif alignments
depicted in Figure 1 is the arrangement of hydrophobic
residues. Examination of the Nova-2 KH3 domain struc-
ture demonstrates that the bulk of the conserved aliphatic
residues (Figure 1) is entirely within the hydrophobic core
(Figure 3; compare with purple residues 12, 17, 20, 28, 37,
39, 41, 56, 58, 68, and 72 in Figure 1), where non-conserv-
ative substitutions would not be tolerated.
The KH3 domains of Nova-1 and Nova-2 are virtually
identical to each other in three-dimensional structure.
Least squares superposition of Nova-1 KH3 structure
(residues 4–20, 27–42, and 52–76) onto the structures of
the four crystallographically independent KH domains
comprising the Nova-2 KH3 asymmetric unit (molecules
A, B, C, and D) yielded root mean square (rms) deviations
of 0.5–0.8 Å (average = 0.6 Å) for α-carbon atomic posi-
tions. Within the Nova-2 KH3 asymmetric unit, pairwise
superposition calculations gave a range of rms deviations of
0.4–0.6 Å (average = 0.45 Å). A more informative estimate
of structural variation would come from measuring the rms
deviations from an average Nova-2 KH3 structure. This
can be estimated by taking the product of the average rms
deviation and the factor [2n/(n–1)]–1/2, where n is the
number of molecules [32], in this case four. The overall
rms deviations become 0.35 Å and 0.25 Å for Nova-1 and
Nova-2, respectively, which is comparable to the error of
the crystallographic method at 2.6 to 2.0 Å resolution [33].
Two loops occur in the Nova KH domain structures,
H1–H2 and S2–S3. The H1–H2 loop corresponds to the
invariant Gly–X–X–Gly segment (yellow in Figures 3–7,
in which X is usually Arg, Lys, or Gly; Figure 1). The bio-
logical role of this segment is unknown but it seems likely
that this superficial basic loop is involved in RNA binding.
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Table 3
Refinement statistics.
Nova-1 KH3 Nova-2 KH3
Resolution (Å) 20.0–2.6 15.0–2.0
Completeness (%)
overall outer shell 93.2/95.6 99.0/99.2
R factor
overall/outer shell 0.245/0.313 0.227/0.323
Free R factor
overall/outer shell 0.310/0.316 0.285/0.328
Rms deviations
bond lengths (Å) 0.014 0.017
bond angles (°) 1.8 2.0
thermal parameters (Å2) – 5.4
The average B factor for all protein atoms in Nova-1 KH3 is 60 Å2 and
for Nova-2 KH3 is 41 Å2 (mean B factor for water molecules = 51 Å2).
The overall PROCHECK G values were 0.14 and 0.13 for Nova-1 and
Nova-2 KH3 domains, respectively [41]. The rms bond lengths and
angles are the respective root mean square deviations from ideal
values. Rms thermal parameter is the rms deviation between the
B values of covalently bonded atomic pairs among mainchain atoms.
The free R factor was calculated with 10% of data omitted from the
structure refinement.
Table 2
Nova-2 KH3 data collection statistics.
Resolution (Å) 15.0–2.0
Number of reflections
measured/unique 104,893/26,001
Completeness (%)
overall/outer shell 99.0/99.2
Rsym*(%)
overall/outer shell 8.8/19.7
Molecular replacement solution
Correlation coefficient (%) 63
Initial R factor (%) 43
*Rsym = ∑|I–〈I〉|/∑I, where I is the observed intensity and 〈I〉 is the
average intensity obtained from multiple observations of symmetry-
related reflections.
The loop is well ordered in two of the four crystallographi-
cally independent Nova-2 KH3 structures (molecules C
and D; see Figure 6), where it points towards the α-helical
face of the KH domain. The S2–S3 loop is the most vari-
able portion of the maxi-KH motif (red in Figures 3a,4–7),
with loop lengths ranging up to 44 residues among the
various KH-protein superfamily members (Figure 1).
Little or no sequence conservation is seen in the S2–S3
loop, with the exception of the STAR family of single
KH-containing molecules [34]. The variable loop is well
defined in only one of the five Nova KH3 crystallographi-
cally independent structures (molecule A of the Nova-2
structure; see Figure 6). In this protomer, the loop forms
crystal-packing contacts with the turn between S1 and H1
in a symmetry-related molecule. The unstructured nature
of this loop in the bulk of our KH domain structures
explains its protease sensitivity (see above).
Comparisons between X-ray and NMR structures of KH
domains
Figure 4 illustrates comparisons of the structures derived
from X-ray crystallography with those derived from NMR
studies. In all cases, the N- and C-terminal limits of orga-
nized secondary structural elements are well correlated
with the definition of the KH domain provided by proteol-
ysis and mass spectrometry of Nova-1 (Figure 2). For
quantitative comparisons, the Nova-2 KH3 structure was
superimposed on five randomly chosen NMR structures
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Figure 3
Structure of a Nova KH domain. Ribbon
stereodrawing of Nova-2 KH3 with conserved
aliphatic residues comprising the hydrophobic
core illustrated in ball-and-stick format. The
invariant Gly–X–X–Gly segment is shown in
yellow, and the variable loop in red. The N and
C termini are indicated. (a) A view of the
β-sheet face of the KH domain. (b) A 90°
rotation from the view shown in (a).
of vigilin KH6 and FMR-1 KH1 using residues 5–42 and
52–76, giving minimum rms deviations of 1.9 and 2.5 Å,
respectively. These values explain why the NMR struc-
tures were not useful for molecular replacement, which
often fails when the rms deviation between the search
model and the unknown structure exceeds 1.0 Å [35].
The most significant differences between the structures
determined by X-ray crystallography and those obtained by
NMR involve two of the three α helices (H3 shows little
variation). H1 does not exist in FMR-1 KH1; the corre-
sponding residues form a poorly defined random coil region
despite conservation in this portion of the sequence. H1
occurs in both the vigilin and Nova structures, but shows
different interactions with the variable region connecting S2
and S3 in the two proteins. Examination of H2 again reveals
that the Nova and vigilin KH domains are quite similar, and
that FMR-1 is an outlier. Instead of forming the edge of the
α/β sandwich, H2 in FMR-1 is approximated to S2 and S3.
NMR spectroscopy was not able to visualise the invariant
H1–H2 segment in the vigilin and FMR-1 KH domains,
suggesting that it is flexible in the absence of interactions
with other macromolecules. In two of the Nova-2 KH3 pro-
tomers, the H1–H2 loop is relatively well defined in the
electron-density map and is seen to point towards the
α-helical face of the KH domain. The S2–S3 loop was also
not well defined in either of the NMR structures, but it is
clearly visible in one of the Nova-2 KH3 domain protomers
where it is bent towards the β-sheet face of the protein.
Structure-based threading analyses of KH domains
With four KH domain structures in hand (vigilin KH6,
FMR-1 KH1, Nova-1 KH3, and Nova-2 KH3), we used
threading [36] to make structure-based alignments for
125 available KH motif sequences (Figure 1). This com-
putational strategy provides an objective measure of
structural similarity between two proteins by ‘threading’
the amino acid sequence of an unknown protein through
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Figure 4
Comparison of Nova KH3 with vigilin KH6 and
FMR-1 KH1 domain structures. (a) Side-by-
side ribbon drawings using the color-coding
scheme and view of Figure 3a.
(b) Superposition of Nova-2 KH3 (blue) on
vigilin KH6 (red), and on FMR-1 KH1 (yellow),
using the view of Figure 3b.
the structure of a homolog (see Materials and methods
section). The validity of the structure-based sequence
alignment can then be calculated using a statistical
approach based on whether or not the sidechains of the
unknown protein are predicted to occupy chemically
appropriate environments. For reference, Z scores > 4–5
indicate ‘sensible’ sidechain environments, implying that
the structure-based sequence alignments are valid. Each
sequence alignment reported in Figure 1 is derived from
the structure-based threading exercise producing the
highest Z score (all sequences were threaded against all
four KH domain structures), except where the Z score
was less than 4.0, in which case manual alignment was
employed (20 of the 125 sequences). The vast majority
(100 of 125) of the threading Z scores are > 4.0, suggest-
ing that most, if not all, KH motifs are structural
homologs of one or more of the four available experimen-
tally determined models. Our two crystal structures gave
the best alignments in over 60% of all cases (79 of 125),
suggesting that the Nova-1 and Nova-2 KH3 domains
represent superior structural models of the KH
super_family (vigilin KH6 gave 23 of 125, FMR-1 KH1
gave 3 of 125).
Inspection of Figure 1 shows that nearly all of the
sequences can be accommodated by the N- and C-termi-
nal limits of the maxi-KH motif, which corresponds to the
proteolytically resistant core of the Nova-1 KH domains.
The only clear exceptions are two proteins, each contain-
ing a single KH domain. SRPM54 does not display
aliphatic conservation in the vicinity of H3 and csrA lacks
any residues in this region. In these cases, the mini-KH
motif [3] may be structurally significant.
Destabilizing effect of a Fragile X point mutation in the KH
domain
Fragile X syndrome, the most common inherited cause of
mental retardation in humans, results from a lack of func-
tionally active FMR-1 protein. FMR-1 contains two KH
domains, and an Ile304→Asn point mutation in KH2
caused a particularly severe case of mental retardation in
one patient [27]. A threading Z score of 4.3 for FMR-1
KH2 was obtained with Nova-2 KH3, suggesting that
inspection of this structure could explain the loss-of-func-
tion phenotype. In both Nova-1 KH3 and Nova-2 KH3,
Leu28, the residue corresponding to FMR-1 Ile304, is a
buried leucine that contributes to the hydrophobic core of
the KH domain. We measured circular dichroism (CD)
spectra for the Leu28→Asn point mutants of the Nova-1
and Nova-2 KH3 domains, and found that they lack orga-
nized secondary structure (data not shown). Analogous
mutations were made by Pastore and coworkers [24,25] in
the vigilin KH6 and FMR-1 KH1 domains, yielding
unfolded proteins as judged by CD spectroscopy. Thus,
Fragile X syndrome mutations in four different recombi-
nant KH domains prepared in two different laboratories
provide overwhelming support for a model in which
FMR-1 is inactivated by a non-conservative substitution
that destabilizes the hydrophobic core of its KH2 domain.
RNA-binding by KH domains
KH motifs were originally identified in hnRNP proteins,
which bind pre-mRNA [37]. Evidence that other KH-
containing proteins interact with RNA is manifold. The
KH domain of a ribosomal protein has been cross-linked
to ribosome-bound mRNA [38]. Vigilin, consisting almost
entirely of KH domains, binds both transfer [39] and
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Figure 5
Potential KH-domain RNA-binding surfaces.
Two faces of the Nova KH3 domain are
shown with putative RNA-interacting residues
(see text) in green and blue as ball-and-stick
models. Blue indicates those residues with
moderate conservation (see Figure 1). The
H2–H3 and S2–S3 loops are color-coded as
in Figure 3. (a) The β-sheet surface, showing
14 potential RNA-binding residues, two of
which show moderate conservation among
KH domains. This view is identical to
Figure 3a. (b) The α-helical surface, showing
15 potential RNA-binding residues, six of
which show moderate conservation. This view
corresponds to a 90° rotation about the
vertical of the view in (a).
messenger RNAs [11]. Proteins belonging to the
FMR/FXR family have also been shown to associate with
ribosomes [40,41], implicating them in RNA binding. A
study of the protein SF1, which contains a single KH
domain, showed that the specificity for RNA binding
depends solely on this domain even though a zinc-finger
region, also capable of binding RNA, is present [42]. A
number of ribo-homopolymer studies have been per-
formed in vitro with KH-containing proteins. These
experiments demonstrated that hnRNP K, PCBP-1 and
PCBP-2 bind poly r(C) [18,43], while Nova-1, Nova-2,
FMR-1, FXR-1, and the Quaking protein bind poly r(G)
and poly r(U) [5,6,20,21,44]. More informative results
came from a study that showed that hnRNP K and E1
together bind a tandem UC-rich, 19 base sequence in the
3′ untranslated region of LOX mRNA [45]. In addition,
three binding-site selection studies have been performed
with KH-containing proteins. First, both Nova proteins
were shown to bind hairpins with UCAU-rich loops
[20,23]. Second, the single-KH-domain protein SAM68
demonstrated a preference for RNA sequences contain-
ing UAAA [46]. Most recently, vigilin was shown to
prefer single-stranded RNAs containing (A)nCU and
UC(A)n sequences [47]. These selection studies suggest
that the KH domain has evolved to become a general
motif for sequence-specific RNA binding.
Regrettably, mutagenesis studies of KH domains have not
conclusively identified their RNA-binding surface(s). Six
separate mutations have been examined in the Caenorhab-
ditis elegans GLD-1 single-KH-domain protein [48].
Gly227→Asp and Gly227→Ser loss-of-function mutations
of the first glycine of the invariant Gly–X–X–Gly loop are
thought to interfere with RNA binding, by restricting the
mobility of this loop and/or by steric interference or elec-
trostatic repulsion by an improperly positioned negative
charge. Two other mutations in GLD-1, Gly248→Arg and
Gly250→Arg, map to the variable loop and result in a
masculinization of germline phenotype. This portion of
the sequence is highly variable in both sequence and
length among KH domains, and is not considered to be a
good candidate for the RNA-binding surface. The remain-
ing GLD-1 mutations, Pro217→Leu and Ala294→Thr,
result in partial loss of function and occur at the semi-con-
served proline between S1 and H1 and at a conserved
hydrophobic residue in the middle of H3. Both of these
mutations are likely to disrupt the KH domain and are
probably not involved in RNA binding. The Drosophila
WHO protein also demonstrates a loss-of-function muta-
tion, Arg185→Cys, in the variable loop that is analogous
to those seen in GLD-1 [13]. In Drosophila Bicaudal C
[19], a Gly295→Arg loss-of-function mutation of the con-
served glycine at the C terminus of S3 probably disrupts
the fold of the KH domain. Finally, an Ile304→Asn muta-
tion in the human FMR-1 KH2 domain [27,49] causes a
particularly severe mental retardation phenotype that is
correlated with unfolding of homologous KH domains 
in vitro (see above).
The structures of other RNA-binding proteins provide
some insights into KH-domain–RNA interactions. Pro-
teins that bind single-stranded RNA frequently employ a
β sheet, as in U1 snRNP A, tRNAGln and tRNAAsp syn-
thetases and the MS2 phage coat protein (reviewed in
[50]). It is remarkable that these proteins possess an α/β
structure similar to that of the KH domain. Furthermore,
α helices have been implicated in binding to double-
stranded RNA or to regions with significant RNA tertiary
structure. Examples include aminoacyl–tRNA synthetases
presenting α helices to stem structures in tRNA, and an
α helix of HIV-1 Rev binding to the major groove of RRE
RNA (reviewed in [50].) Given that the Nova proteins rec-
ognize single-stranded RNA, it is likely that the antiparal-
lel β sheet participates in RNA binding.
A detailed analysis of several RNA–protein structures
([51–55], PDB codes 1GTR, 1URN, 1SES, 1ZDI and
1A9N, respectively) revealed the amino acid residues that
are most likely to be involved in high-affinity RNA
binding. Twelve residue types make a total of 73 direct
contacts between their sidechains and RNA nucleotides,
three of which occur with low frequency (Phe, Leu, Pro).
In the nine residue types that interact ‘frequently’ with
RNA we observe the following: Arg, Asn, Lys and Ser
interact with the RNA phosphate backbone; Arg, Glu,
Lys, Gln, Thr and Ser with the sugar ring; Arg, Glu, Asn,
Lys, Asp, Tyr, Gln, Thr and Ser with the nucleotide
bases. No clear read-out mechanism is apparent from
these associations. The location of these putative RNA-
binding residues in Nova-2 KH3, however, suggests two
candidate RNA-binding surfaces for KH domains
(Figure 5). The first is the surface of the β sheet, and the
other is created by juxtaposition of the three α helices
onto the opposite face of the molecule. The only available
objective evidence (cross-linking of mRNA to H2 in a
ribosomal protein [38]) suggests that the second candidate
surface interacts with RNA. Conversely, the α/β structure
of the KH domain implicates the β sheet in RNA binding.
We must, therefore, await a structure of a KH domain
bound to its cognate RNA before this question can be
resolved. In the interim, site-directed mutagenesis of the
two candidate surface regions may provide useful informa-
tion. In particular, mutations in residues at positions 53
and 57 (indicated in blue on the β-sheet face; Figure 5a)
and at positions 23, 24, 27, 29, 33, 35 (indicated in blue on
the α-helical face; Figure 5b) could help elucidate which
KH domain residues are involved in RNA binding.
Proteins with multiple KH domains
Most members of the KH superfamily contain more than
one KH motif, with some including as many as fifteen
(Figure 1). What are the likely functional consequences of
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forming linear arrays of KH domains? Linking of KH
domains could increase the RNA-binding surface to
support recognition of a relatively long sequence of RNA,
as seen for zinc-finger transcription factors binding pro-
moter DNA (reviewed in [56]). Multiple KH domains
might also permit simultaneous binding to multiple RNA
targets (e.g., specific mRNA recruitment to the ribosome
during translation). Finally, it is conceivable that some KH
domains bind other proteins.
In order to address these issues, it would be useful to
know the arrangement of multiple KH domains relative to
each other. Do they function as spatially independent,
loosely joined modules, or do they form more ordered
interactions? Our Nova-1 and Nova-2 crystals are both
composed of KH domain tetramers with 22 symmetry. In
Nova-2 KH3, noncrystallographic 22 symmetry generates
the asymmetric unit (Figure 6). For Nova-1 KH3, the four
molecules in the tetramer are related by crystallographic
22 symmetry. The Nova-1 and Nova-2 tetramers are very
similar to each other with a backbone rms deviation of
1.35 Å for all common α-carbon atoms. Our hydrodynamic
studies of the KH3 domains ruled out oligomerization in
aqueous solution at concentrations below about 0.7 mg/ml
(see above), suggesting that tethering would be required
to reproduce the crystal lattice interactions at physiological
protein concentrations. It should be emphasized that the
Nova KH3 domain tetramers occur in two different space
groups, effectively ruling out crystal-packing artifacts.
Analysis of the Nova-2 KH3 tetramer suggests two possi-
ble KH-domain dimer interfaces. The a dimer is stabilized
by packing of the H3 α helices (Figure 7a). The b dimer is
stabilized by interactions between the edges of the two
β sheets (Figure 7b). Both dimer interfaces could repre-
sent biologically relevant modes of KH-domain interaction
because they bury more surface area than a typical crystal
packing interaction (reviewed in [57]). Inspection of the
two interfaces, however, provides an argument for the
b dimer. Hydrophobic residues buried in the a dimer
include Leu34, Ala67, Tyr70, and Leu71, none of which is
conserved in the KH domain superfamily. In the b inter-
face, Glu6, Val8, Met10, Pro62, Gln66, and Gln69 are
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Figure 7
Alternative KH domain dimers from the 22 tetramer. Individual KH
domains are color-coded as in Figure 6 with modeled linker residues in
black, the invariant Gly–X–X–Gly segment in yellow, and the variable
loop in red. Twofold axes are denoted by the arrow and disk. The a and
b dimers bury 1200 and 950 Å2, respectively. For reference, a typical
lattice packing interaction buries < 600 Å2 (reviewed in [57]). (a) The
α-helix a dimer. (b) The β-sheet b dimer.
Figure 6
Nova KH domain 22 tetramer. Ribbon drawing showing the asymmetric
unit comprising the monoclinic Nova-2 KH3 crystals with the twofold
axes indicated by arrows. The tetragonal Nova-1 KH3 crystals
demonstrate a similar crystallographic 22 tetramer. Each Nova-2 KH3
domain protomer is color-coded: cyan, A; green, B; blue, C; magenta,
D. The H1–H2 and S2–S3 loops are color coded as in Figure 3.
Missing loop regions have been included as modeled connections.
buried upon dimer formation. Three of these residues (6,
8, and 10) constitute conserved hydrophobics in the KH-
domain superfamily. In addition, the gap between the N
and C termini in the a dimer is 21 Å, which is incompati-
ble with many inter-KH-domain linkers (Figure 1). In the
b dimer, this distance is only 13 Å, which could be
spanned by a tetrapeptide in an extended conformation,
accommodating virtually all known inter-KH-domain
linkers (Figure 1). FMR-1 represents a biologically impor-
tant example of two KH domains connected by a short
linker. Preliminary modeling of the FMR-1 KH1–KH2
structure has been performed using the Nova-2 b dimer,
with the NMR structure of the FMR-1 KH1 and Nova-2
KH3 (Z score for its alignment with FMR-1 KH2 was 4.3).
The resulting double KH domain structure (not shown,
but similar to Figure 7b) would permit access to both
putative RNA-binding surfaces (α helix and β sheet) of
the two KH domains.
Biological implications
K-homology motifs have been found in a wide range of
RNA-binding proteins that have diverse functions
in vivo. To understand how these proteins work in the
cell it is important to understand how KH domains inter-
act with RNA and why KH domains occur in linear
arrays. Nova-1 and Nova-2 are biologically important
neuronal RNA-binding proteins, each of which contains
three KH domains. The structure of the third KH
domain of each protein was determined by X-ray crys-
tallography, providing detailed insights into the architec-
ture of these domains as well as possible RNA-binding
surfaces. These X-ray structures enable the invariant
Gly–X–X–Gly segment and the variable loop region to
be visualized for the first time. The crystal structures
also provide high-resolution models of the KH motif,
allowing more accurate identification and alignment of
KH superfamily members. Analysis of conservation pat-
terns among surface-accessible regions permitted identi-
fication of two putative RNA-binding surfaces. Nova-1
and Nova-2 KH3 domains both adopt 22 symmetry in
the crystal lattice, yielding very similar tetrameric struc-
tures. The dimer interfaces generating the KH-domain
tetramers may represent the arrangement of individual
KH domains in multi-KH-containing proteins. The
information provided by our KH-domain crystal struc-
tures should significantly aid in efforts to understand
how KH proteins recognize RNA and how KH domains
might interact with one another in vivo.
Materials and methods
KH domain expression, renaturation, purification, and
characterization
Nova-1 and Nova-2 KH domains were expressed in E. coli
[BL21(DE3)pLysS] at 37°C. The cells were collected via centrifugation
and lysed by three cycles of freeze/thaw. The insoluble fraction was dis-
solved in 6M guanidine–HCl and applied to a cation-exchange column,
and the protein was refolded on the resin via gradual renaturation and
eluted. An N-terminal His tag was subsequently removed through
digestion with TEV protease (Gibco BRL), followed by a final cation-
exchange column to isolate the cleaved protein. The purified proteins
were characterized using electrospray mass spectrometry to confirm
the correct mass (Nova-1 KH3 observed = 8,106 ± 3 Da versus a pre-
dicted 8,104 Da; Nova-2 KH3 observed = 8,528 ± 3 Da versus a pre-
dicted 8,526 Da). Circular dichroism spectroscopy was employed to
confirm proper folding, and dynamic light scattering was used to
demonstrate monodispersity prior to crystallization trials.
Proteolysis and mass spectrometry
Full length Nova-1 was expressed as a soluble protein in E. coli, purified
using cation exchange chromatography, and mixed with various pro-
teases (Asp-N, Glu-C, trypsin, and chymotrypsin) in separate reactions
[26]. The masses of the resulting fragments were determined using a
matrix-assisted laser desorption ionization time of flight mass spectrom-
eter [58]. Interpretation of the fragment masses allowed reconstruction
of the cleavage history of each reaction. From these data, regions of
protection from protease were identified. The reactions were repeated
with a 21-mer RNA containing three UCAU repeats (5′-GGGAGU-
CAUUUCAUCUCAUCA-3′) in the ratio 1.5:1 RNA:protein to identify
regions of RNA-dependent proteolysis protection.
Dynamic light scattering
Dynamic light scattering measurements were made using a DynaPro
Molecular Sizing Instrument (Protein Solutions Inc., Charlottesville, VA).
Measurements in the concentration range 0.3 to 1.0 mM for both
Nova-1 and Nova-2 KH3 domains were made in buffers containing 50
to 400 mM NaCl, 50 mM HEPES pH 7 at room temperature. The
results demonstrated that the protein preparations were monodisperse,
giving an apparent molecular weight of a KH domain dimer for the
oligomeric species undergoing Brownian motion in solution. These
findings were independent of protein and salt concentration.
Analytical ultracentrifugation
Sedimentation equilibrium measurements were made to determine the
oligomerization state of the Nova KH3 proteins in aqueous solution at
lower concentrations. Data were collected with an XL-A analytical ultra-
centrifuge (Beckmann, Fullerton, CA) and processed using the manu-
facturer’s software. Nova-1 KH3 Ala37→Cys and wild-type Nova-2
KH3 were dissolved in buffers containing 50 mM to 2 M NaCl with
50 mM HEPES pH 7 and were examined at 32,000, 38,000, and
45,000 rpm. No significant evidence of KH domain oligomerization was
detected under the experimental conditions. Sample absorption at
280 nm precluded studies at concentrations comparable to those used
for dynamic light scattering.
Crystallization conditions
Nova-1 KH3 crystals were grown via vapor diffusion following streak-
seeding of sitting and hanging drops at 20°C. The reservoir contained
1.8 M Li2SO4 with 100 mM NaAc pH 4.0. Protein solutions (typically
10 mg/ml in 300 mM NaCl, 20 mM HEPES pH 7) were mixed in a ratio
of 1:1 with reservoir solution and the drops allowed to equilibrate for
24 h, before streaking. Large (0.4 × 0.4 × 0.6 mm3) bipyramidal crystals
appeared within a few days. Dimercuric acetate (DMA), Baker’s dimer-
curial (Bakers), and ethyl mercury phosphate (EMP) were indepen-
dently soaked into various Nova-1 KH3 Ala37→Cys crystals at
concentrations of 1 mM for 24 h for phase determination. Nova-2 KH3
crystals were grown by vapor diffusion at 4°C using sitting and hanging
drops. The reservoir contained 1.4 M (NH4)2SO4 with 2% MPD and
50 mM Formic acid, pH 3.0. Moderately sized (0.2 × 0.2 × 0.4 mm3)
rectangular parallel piped crystals grew within two to four weeks, fol-
lowing equilibration and streak seeding as above.
X-ray data collection and processing
Diffraction data from Nova-1 KH3 crystals were collected at 4°C using
CuKα radiation with a Rigaku RAXIS-IIc imaging plate area detector,
and processed using DENZO and SCALEPACK [59]. The crystals
were obtained in the tetragonal space group P42212 (a = b = 44.7 Å,
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c = 84.0 Å) with one Nova-1 KH3 domain/asymmetric unit giving a
Matthews number of 2.6 Å3/Da. The phase problem was solved at
2.9 Å resolution by multiple isomorphous replacement with anomalous
scattering (MIRAS) using three mercury derivatives with the program
MLPHARE [60]. Excellent electron density was visible in the experimen-
tal MIRAS map, allowing rapid modeling of the KH domain using the
program O [61]. Continued model building interspersed with positional
and simulated annealing refinement plus grouped B refinement using
the program CNS [31] produced the current refinement model for the
Ala37→Cys mutant consisting of Nova-1 residues 5–73. Residues with
poorly defined sidechain density were modeled as alanines (5, 23, 26,
38, 43, 52, 55, 75). The electron density for the polypeptide backbone
is everywhere continuous at 1.3σ in a (2|Fobserved|–|Fcalculated|) difference
Fourier synthesis, except between residues 22–25 (invariant segment)
and 43–49 (variable loop), where breaks occur.
Nova-2 KH3 crystals were frozen in liquid propane after brief immersion
in 25% MPD/5% PEG MME 5000 cryoprotectant. Data were collected
to 2.0 Å resolution at –160°C using beamline F2 at the Cornell High
Energy Synchrotron Source. The crystals were obtained in the mono-
clinic space group C2 (a = 66.5 Å, b = 61.1 Å, c = 97.3 Å, β = 98.2°)
with four Nova-2 KH3 molecules/asymmetric unit giving a Matthews
number of 2.9 Å3/Da. Using the Nova-1 KH3 structure as a search
model, the program AMORE [60] gave one high quality molecular
replacement solution, and convergence was achieved with positional
and simulated annealing refinement using the program CNS (Table 1).
The current model consists of Nova-2 residues 4–77 (protomer A),
4–79 (B), 4–77 (C), and 4–76 (D), plus 230 hydration waters.
Residues with poorly defined sidechain density were modeled as ala-
nines (protomer A: 5, 23, 26, 38, 43, 52, 75; B: 5, 38, 40, 52, 55; C:
5, 23, 52, 55, 75, 77; D: 4, 5, 23, 52). The electron density for the
polypeptide backbone is everywhere continuous at 1.3σ in a (2|Fob-
served|–|Fcalculated|) difference Fourier synthesis, except between
residues 23–24 and 49–50 in protomer A, 21–26 and 43–50 in B,
43–50 in C, and 43–51 in D where breaks occur.
Threading calculations
The program Threader 2 [62] was employed to thread the sequences
of the 125 individual KH domains (Figure 1) onto each of the four cur-
rently known KH structures: Nova-1 KH3, Nova-2 KH3, vigilin KH6, and
FMR-1 KH1. A pool of 200, randomly chosen reference structures were
selected from the 2000 provided with the program to reduce process-
ing requirements. The Z scores reported in Figure 1 are the weighted
sum of pairwise and solvation energies, filtered for the set of proteins
with a reasonable proportion of the sequence and structure matched.
Accession numbers
Genbank accession numbers for the KH-containing proteins used in
the alignment are: Hs_a-CP-1, U24223; Hs_AKAP149, X97335;
Ce_B0280 U10438; Dm_BIC-C, U15928; Ce_C06G4, L25598;
Ce_C56G2, U23177; Mm_CBP, X75947; Ec_CSRA, L07596;
Hs_FMR-1, S65791; Hs_FUSE, U05040; Hs_FXR-1, U25165;
Hs_FXR-2, U31501; Hs_GLD-1, U20535; As_GRP, J03453;
Hs_HNRNP-E1, X78137; Hs_HNRNP-E2, X78136; Hs_HNRNP-K,
S74678; Dm_HOW, U72331; Hs_KOC, U97188; Hs_KSRP,
U94832; Ce_M88, Z34802; Sc_MER-1, M31304; Ce_MEX-3,
U67864; Hs_NOVA-1, U67864; Ec_NUSA, X00513; Ec_PNP,
J02638; Hs_SAM68, M88108; Sc_SCP160, X65645; Hs_SF1,
AJ000051; Dm_PSI, S75665; Mm_SRPM54, M91593; Xl_VG1,
AF064634; Gg_VIG, X65292; Sc_YBL0418, X77291; Sc_YBR232c,
Z36101; Gg_ZBP1, AF026527; Ce_ZK418, U000047. The sequence
for Hs_NOVA-2 was obtained from [20]. The atomic coordinates for  
the Nova-1 and Nova-2 KH domains will be submitted to the Protein 
Data Bank.
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